Home›Stock Screener›Zenotech Laboratories›Financial Statements

Zenotech Laboratories Complete Financial Statements

13 Years of Data
2026 - 2006

In FY2006, Zenotech Laboratories (ZENOTECH) reported revenue ₹6 Cr, net profit ₹1 Cr and EPS ₹0.00, with a net profit margin of 16.7% and ROE of 1.1%. Full financial statements from FY2006 to FY2026 (13 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Zenotech Laboratories stock price NSE.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 16.67% 2006 data
EBITDA Margin 33.33% 2006 data
Operating Margin 24.00% 2006 data
Return on Assets 0.90% 2006 data
Return on Equity 1.05% 2006 data

Balance Sheet Ratios

Current Ratio 10.25 2006 data
Equity Ratio 85.59% 2006 data
Asset Turnover 0.05 2006 data

ZENOTECH Revenue, Net Profit & EBITDA — Year-on-Year Growth

ZENOTECH YoY (Jun 2006 vs Sept 2006) — revenue +100.0%, net profit +150.0%, EBITDA +300.0%. Review ZENOTECH P/E ratio to evaluate earnings-based valuation against sector peers.

Revenue Growth
+100.0%
Year-over-Year
Net Profit Growth
+150.0%
Year-over-Year
EBITDA Growth
+300.0%
Year-over-Year
Equity Growth
-1.0%
Year-over-Year
Operating Cash Flow Growth
-16.7%
Year-over-Year
Investing Cash Flow Growth
+171.4%
Year-over-Year

ZENOTECH Income Statement — Revenue, EBITDA & Net Profit

Zenotech Laboratories revenue ₹6 Cr, EBITDA ₹2 Cr, net profit ₹1 Cr, EPS ₹0.00 (2006) — net profit margin 16.7%. Explore ZENOTECH intrinsic value to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars Sept 2006 Jun 2006
Revenue 6 3
Expenses 4 4
EBITDA 2 -1
Operating Profit Margin % 24.00% -52.00%
Depreciation 0 0
Interest 0 0
Profit Before Tax 1 -2
Tax 0 0
Net Profit 1 -2
Earnings Per Share (₹) 0.00 0.00

ZENOTECH Balance Sheet — Assets, Liabilities & Shareholders' Equity

ZENOTECH total assets ₹111 Cr, total equity ₹95 Cr, total liabilities ₹ Cr (2026) — ROE 1.1%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 111 111 106 101 94 86 86 85 82 51 53 64
Current Assets 41 36 26 16 7 7 6 19 31 2 3 9
Fixed Assets 66 61 66 65 71 74 49 43 44 47 48 52
Capital Work in Progress 4 4 2 5 0 2 29 17 2 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Assets 0 47 39 31 23 9 8 25 35 4 5 12
LIABILITIES
Total Liabilities
Current Liabilities 4 2 2 2 8 23 1 0 0 0 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 95 96 91 82 71 48 50 39 42 -66 -46 -27
Share Capital 61 61 61 61 61 61 61 61 61 34 34 34
Reserves & Surplus 34 35 30 21 10 -13 -11 -22 -19 -100 -81 -62

ZENOTECH Cash Flow Statement — Operating, Investing & Financing

Zenotech Laboratories operating cash flow ₹10 Cr, investing ₹15 Cr, financing ₹0 Cr, net cash flow ₹25 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 10 12 21 18 6 11 -14 -16 2 -5 -8
Investing Activities 15 -21 -6 -2 -5 -21 -16 -3 -1 6 0
Financing Activities 0 0 -6 -16 0 -3 15 47 -1 -1 7
Net Cash Flow 25 -9 9 0 1 -12 -15 28 0 0 -1